Whole-blood cultures from renal-transplant patients stimulated ex vivo show that the effects of cyclosporine on lymphocyte proliferation are related to P-glycoprotein expression

Transplantation

Volumn 77, Issue 4, 2004, Pages 557-561

  Singh, Dave ^a,c   Alexander, John ^b   Owen, Andrew ^a   Rustom, Rana ^a,b   Bone, Mike ^b   Hammad, Abdel ^b   Roberts, Norman ^b   Park, Kevin ^a   Pirmohamed, Munir ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; PHYTOHEMAGGLUTININ; TUBERCULIN;

ADULT; AGED; ARTICLE; BLOOD CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADMINISTRATION, ORAL; ADULT; AGED; CELL DIVISION; CELLS, CULTURED; CYCLOSPORINE; CYTOSINE; DRUG RESISTANCE; FEMALE; GENES, MDR; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOCYTES; MALE; MIDDLE AGED; P-GLYCOPROTEIN; PHYTOHEMAGGLUTININS; POLYMORPHISM, GENETIC; THYMINE; TUBERCULIN;

EID: 1442360354     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000114594.21317.A5     Document Type: Article

References (31)

1. Ferron G, Jusko W. Species- and gender-related differences in cyclosporine/prednisolone/sirolimus interactions in whole blood lymphocyte proliferation assays. J Pharmacol Exp Ther 1998; 286: 191.
2. Stein M, Murray J, Wood A. Inhibition of stimulated interleukin-2 production in whole blood: a practical measure of cyclosporin effect. Clin Chem 1999; 45: 1477.
3. Singh SD, Booth CG. Tuberculin-induced lymphocyte proliferation in whole blood: an antigen specific method for assessing immunosuppressive agents. J Immunol Methods 2002; 260: 149.
4. De Groote D, Zangerle P, Gevaert Y, et al. Direct stimulation of cytokines (IL-1β, TNF-α, IFN-γ and GM-CSF) in whole blood: comparison with isolated PBMC stimulation. Cytokine 1992; 4: 239.
5. Kasahara K, Strider R, Chensue S, et al. Mononuclear cell adherence induces neutrophil chemotactic factor (interleukin-8) gene expression. J Leukocyte Biol 1991; 50: 287.
6. Van den Berg AP, Twilhaar WN, Mesander G, et al. Quantitation of immunosuppression by flow cytometric measurement of the capacity of T cells for interleukin-2 production. Transplantation 1998; 65: 1066.
7. Seelig A. A general pattern for substrate recognition by P-glycoprotein. Eur J Biochem 1998; 251: 252.
8. Fricker G, Drewe J, Huwyler J, et al. Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation. Br J Pharmacol 1996; 118: 1841.
9. Thiebaut F, Tsuruo T, Hamada H, et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A 1987; 84: 7735.
10. Fakata KL, Elmquist WF, Swanson SA, et al. Cyclosporin A has low potency as a calcineurin inhibitor in cells expressing high levels of P-glycoprotein. Life Sci 1998; 62: 2441.
11. Kemnitz J, Uysal A, Haverich A, et al. Multidrug resistance in heart transplant patients: a preliminary communication on a possible mechanism of therapy-resistant rejection. J Heart Lung Transplant 1991; 10: 201.
12. Gotzl M, Wallner J, Gsur A, et al. MDR1 gene expression in lymphocytes of patients with renal transplants. Nephron 1995; 69: 277.
13. Hoffmeyer S, Burk O, von Richter O, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci U S A 2000; 97: 3473.
14. Hitzl M, Drescher S, van der Kuip H, et al. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. Pharmacogenetics 2001; 11: 293.
15. Tanabe M, Ieiri I, Nagata N, et al. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. J Pharmacol Exp Ther 2001; 297: 1137.
16. Hamwi A, Veitl M, Manner G, et al. Evaluation of four automated methods for determination of whole blood cyclosporine concentrations. Am J Clin Pathol 1999; 112(3): 358.
17. Petrevsky N, Harrison L. Diurnal rhythmicity of human cytokine production: a dynamic disequilibrium in T helper cell type 1/T helper cell type 2 balance? J Immunol 1997; 158: 5163.
18. Entzian P, Linnemann K, Schlaak M, et al. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med 1996; 153: 1080.
19. Licastro F, Davis L, Morini M. Lectins and superantigens: membrane interactions of these compound with T lymphocytes affect immune responses. Int J Biochem 1993; 25: 845.
20. Delaney MP, Smythe E, Higgins RM, et al. Constitutive and acquired resistance to calcineurin inhibitors in renal transplantation: role of P-glycoprotein-170. Transpl Int 2000; 13(4): 276.
21. Batiuk TD, Pazderka F, Enns J, et al. Cyclosporine inhibition of leukocyte calcineurin is much less in whole blood than in culture medium. Transplantation 1996; 61: 158.
22. Von Ahsen N, Richter M, Grupp C, et al. No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients. Clin Chem 2001; 47(6): 1048.
23. Parasrampuria DA, Lantz MV, Benet LZ. A human lymphocyte based ex vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function. Pharm Res 2001; 18: 39.
24. Koziolek MJ, Riess R, Geiger H, et al. Expression of multidrug resistance P-glycoprotein in kidney allografts from cyclosporine A-treated patients. Kidney Int 2001; 60: 156.
25. Hauser IA, Koziolek M, Hopfer U, et al. Therapeutic concentrations of cyclosporine A, but not FK506, increase P-glycoprotein expression in endothelial and renal tubule cells. Kidney Int 1998; 54: 1139.
26. Garcia del Moral R, O'Valle F, Andujar M, et al. Relationship between P-glycoprotein expression and cyclosporin A in kidney. An immunohistological and cell culture study. Am J Pathol 1995; 146: 398.
27. Asghar A, Gorski JC, Haehner-Daniels B, et al. Induction of multidrug resistance-1 and cytochrome P450 mRNAs in human mononuclear cells by rifampin. Drug Metab Dispos 2002; 30(1): 20
28. Nakamura T, Sakaeda T, Horinouchi M, et al. Effect of the mutation (C3435T) at exon 26 of the MDR1 gene on expression level of MDR1 messenger ribonucleic acid in duodenal enterocytes of healthy Japanese subjects. Clin Pharmacol Ther 2002; 71(4): 297.
29. Sakaeda T, Nakamura T, Horinouchi M, et al. MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects. Pharm Res 2001; 18: 1400.
30. Kim RB, Leake BF, Choo EF, et al. Identification of functionally variant MDR1 alleles among European Americans and African Americans. Clin Pharmacol Ther 2001; 70(2): 189.
31. Fellay J, Marzolini C, Meaden ER, et al. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet 2002; 359: 30.